As I understand it, any current shareholder who sells today will be selling ex entitlement and therefore will still be entitled to their allocation of the new shares. The new buyer isn't the registered owner until after the normal T+2 settlement. Of course this all depends on the shares being registered at the correct date and there are no delays or fails ito deliver. In a recent CR of Spartan (SPR) in which I was entitled an allocation, my single purchase of the shares was split in two with a portion not being registered by the registry, Automic, until the day after the cut off date for the entitlement. This reduced my entitlement by a few hundred shares. As it turned out the market price of SPR briefly dropped below the issue price of the new entitlement so I just bought what I wanted on the market and did not take up the offer, but it could have been an isssue.
This is a bit off topic but just a word to the shareholders here who are intending to buy the maximum allocation of DEG shares at $1.10, just check that the number you are entitled to is correct!
- Forums
- ASX - By Stock
- DEG
- Ann: Underwritten A$600M Equity Raising
Ann: Underwritten A$600M Equity Raising, page-79
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DEG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.37 |
Change
0.010(0.74%) |
Mkt cap ! $3.307B |
Open | High | Low | Value | Volume |
$1.34 | $1.40 | $1.33 | $10.11M | 7.349M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 239293 | $1.37 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.38 | 7891 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14845 | 1.510 |
1 | 72800 | 1.480 |
1 | 168931 | 1.475 |
3 | 95067 | 1.470 |
1 | 293 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.240 | 35234 | 1 |
1.275 | 48 | 1 |
1.295 | 163232 | 4 |
1.305 | 66495 | 7 |
1.310 | 291485 | 8 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
DEG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online